LEGEND BIOTECH CORP's ticker is LEGN and the CUSIP is 52490G102. A total of 89 filers reported holding LEGEND BIOTECH CORP in Q2 2021. The put-call ratio across all filers is 0.54 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $6,717,000 | -42.5% | 100,000 | -40.9% | 0.08% | -43.2% |
| Q2 2023 | $11,687,124 | +84.4% | 169,305 | +28.8% | 0.14% | +61.6% |
| Q1 2023 | $6,338,037 | -8.6% | 131,440 | -5.4% | 0.09% | -7.5% |
| Q4 2022 | $6,937,233 | +29.3% | 138,967 | +5.7% | 0.09% | +24.0% |
| Q3 2022 | $5,365,000 | -91.7% | 131,500 | -88.8% | 0.08% | -92.4% |
| Q2 2022 | $64,408,000 | +51.3% | 1,171,051 | 0.0% | 0.99% | +43.7% |
| Q1 2022 | $42,556,000 | -38.3% | 1,171,051 | -20.8% | 0.69% | -30.0% |
| Q4 2021 | $68,921,000 | -7.8% | 1,478,666 | +0.0% | 0.99% | -19.2% |
| Q3 2021 | $74,758,000 | +567.0% | 1,478,594 | +441.5% | 1.22% | +484.2% |
| Q2 2021 | $11,208,000 | -7.7% | 273,043 | -36.7% | 0.21% | -35.1% |
| Q4 2020 | $12,149,000 | +47.2% | 431,418 | +122.5% | 0.32% | -1.5% |
| Q2 2020 | $8,251,000 | – | 193,857 | – | 0.33% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| FengHe Fund Management Pte. Ltd. | 526,072 | $21,595,000 | 11.36% |
| Consonance Capital Management LP | 1,647,497 | $67,630,000 | 8.14% |
| Johnson & Johnson Innovation - JJDC, Inc. | 1,629,173 | $66,878,000 | 6.84% |
| MATTHEWS INTERNATIONAL CAPITAL MANAGEMENT LLC | 1,342,442 | $55,107,000 | 2.29% |
| Vivo Capital, LLC | 956,702 | $39,273,000 | 1.70% |
| Hudson Bay Capital Management LP | 1,878,374 | $77,107,000 | 0.93% |
| Capital International Sarl | 220,470 | $9,050,000 | 0.78% |
| Capital International, Inc./CA/ | 1,951,845 | $80,123,000 | 0.72% |
| Avidity Partners Management LP | 625,000 | $25,656,000 | 0.69% |
| INDUS CAPITAL PARTNERS, LLC | 94,678 | $3,887,000 | 0.66% |